Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vericel (VCEL) Research & Development (2016 - 2025)

Vericel (VCEL) has disclosed Research & Development for 16 consecutive years, with $7.3 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 47.33% to $7.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.6 million through Dec 2025, up 11.15% year-over-year, with the annual reading at $27.6 million for FY2025, 11.15% up from the prior year.
  • Research & Development hit $7.3 million in Q4 2025 for Vericel, up from $6.3 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $7.4 million in Q2 2024 to a low of $3.6 million in Q1 2021.
  • Historically, Research & Development has averaged $5.5 million across 5 years, with a median of $5.2 million in 2022.
  • Biggest YoY gain for Research & Development was 47.33% in 2025; the steepest drop was 8.58% in 2025.
  • Year by year, Research & Development stood at $3.9 million in 2021, then soared by 33.66% to $5.2 million in 2022, then dropped by 6.56% to $4.9 million in 2023, then increased by 0.45% to $4.9 million in 2024, then soared by 47.33% to $7.3 million in 2025.
  • Business Quant data shows Research & Development for VCEL at $7.3 million in Q4 2025, $6.3 million in Q3 2025, and $6.7 million in Q2 2025.